NCT03309150 2024-11-29ATRi Transition Rollover StudyMerck KGaA, Darmstadt, GermanyPhase 1 Completed1 enrolled 4 charts
NCT05246111 2024-11-22Berzosertib Human Mass Balance Study (DDRiver Solid Tumors 208)Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyPhase 1 Completed6 enrolled 30 charts